🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/08/2013 | 26,51 | 27,36 | 26,31 | 27,27 | +2,51% | 3,95% | 177.132 |
| 09/08/2013 | 26,54 | 27,26 | 26,23 | 26,60 | -0,40% | 3,85% | 242.534 |
| 08/08/2013 | 27,76 | 28,10 | 26,61 | 26,71 | -3,17% | 5,37% | 419.505 |
| 07/08/2013 | 28,03 | 28,05 | 27,49 | 27,58 | -2,26% | 2,00% | 470.961 |
| 06/08/2013 | 29,31 | 29,44 | 28,08 | 28,22 | -3,70% | 4,62% | 317.875 |
| 05/08/2013 | 29,10 | 29,59 | 29,07 | 29,30 | +0,82% | 1,80% | 317.715 |
| 02/08/2013 | 28,23 | 29,88 | 22,97 | 29,06 | -4,96% | 24,48% | 968.533 |
| 01/08/2013 | 29,97 | 31,43 | 29,23 | 30,58 | +3,46% | 7,37% | 461.985 |
| 31/07/2013 | 29,81 | 30,51 | 29,23 | 29,56 | -0,75% | 4,29% | 298.799 |
| 30/07/2013 | 29,58 | 30,55 | 29,58 | 29,78 | +0,80% | 3,29% | 263.213 |
| 29/07/2013 | 30,49 | 30,49 | 29,26 | 29,54 | -3,11% | 4,03% | 222.977 |
| 26/07/2013 | 30,80 | 30,88 | 29,57 | 30,49 | +0,39% | 4,25% | 178.093 |
| 25/07/2013 | 29,91 | 30,43 | 28,71 | 30,37 | +1,63% | 5,76% | 317.234 |
| 24/07/2013 | 29,00 | 30,09 | 28,54 | 29,89 | +4,04% | 5,36% | 346.248 |
| 23/07/2013 | 31,22 | 31,72 | 28,48 | 28,73 | -7,27% | 10,39% | 833.079 |
| 22/07/2013 | 29,68 | 31,20 | 29,64 | 30,98 | +4,75% | 5,23% | 281.487 |
| 19/07/2013 | 29,76 | 29,85 | 29,28 | 29,58 | -0,94% | 1,93% | 414.536 |
| 18/07/2013 | 28,40 | 29,94 | 28,23 | 29,86 | +5,65% | 6,04% | 719.266 |
| 17/07/2013 | 27,64 | 28,32 | 27,45 | 28,26 | +2,65% | 3,14% | 324.928 |
| 16/07/2013 | 28,02 | 28,02 | 27,16 | 27,53 | -1,28% | 3,07% | 455.733 |
| 15/07/2013 | 28,10 | 29,06 | 27,46 | 27,89 | +1,92% | 5,71% | 604.171 |
| 12/07/2013 | 26,53 | 28,00 | 26,53 | 27,36 | +2,69% | 5,55% | 414.536 |
| 11/07/2013 | 27,12 | 27,14 | 26,28 | 26,64 | -0,26% | 3,17% | 322.684 |
| 10/07/2013 | 27,07 | 27,07 | 26,57 | 26,71 | -1,38% | 1,87% | 210.955 |
| 09/07/2013 | 26,93 | 27,55 | 26,84 | 27,09 | +1,52% | 2,64% | 477.534 |
| 08/07/2013 | 25,07 | 26,77 | 24,75 | 26,68 | +6,84% | 8,09% | 637.032 |
| 05/07/2013 | 25,03 | 25,95 | 24,45 | 24,97 | +1,62% | 5,98% | 167.353 |
| 03/07/2013 | 23,99 | 24,85 | 23,75 | 24,57 | +1,81% | 4,60% | 193.322 |
| 02/07/2013 | 24,95 | 24,97 | 24,05 | 24,14 | -3,03% | 3,67% | 657.871 |
| 01/07/2013 | 24,09 | 27,87 | 24,09 | 24,89 | +6,68% | 15,69% | 1.780.612 |